Photo: David M. Altshuler
David M. Altshuler, MD, PhD
Year elected: 2006
Current membership category: Senior
Professor of Genetics and Medicine
Harvard Medical School and Massachusetts General Hospital
Broad Institute of Harvard and MIT
Richard B. Simches Research Center
185 Cambridge St., CPZN 6818
Boston, MA 02114-2790
United States of America
Phone: 617-726-5940
Mobile: —
Facsimile: 617-726-6893
Email:

Have an assistant?

Institutional affiliations

Honors and awards

National Academy of Medicine (2010)
American Academy of Arts & Sciences (2013)

Biographical statement

David Altshuler’s laboratory aims to characterize and catalogue patterns of David M. Altshuler, M.D., Ph.D., is Professor of Genetics and Medicine at MGH and HMS, and Director, Program in Medical and Populations Genetics at the Broad Institute. For the past decade Dr. David Altshuler’s group has aimed to make possible the discovery of novel processes causal in common human diseases through studies of inherited genomic variation. His approach has been to characterize and catalogue patterns of human genetic variation, to develop methods for genome-wide studies of sequence variants (single nucleotide and copy number variants both common and rare), and to apply these methods to dissect the genetic contribution of type 2 diabetes and other diseases. Specifically, Dr. Altshuler’s lab contributed to understanding patterns of genetic variation in the human genome, characterizing SNPs and copy number variants, linkage disequilibrium properties, and the underlying influence of recombination rate and population history. They led in the creation of the public genome-wide SNP map, and the International Haplotype Map Project. They contributed to development of microarray methods for genome-wide measurement of genetic variation, and to statistical methods for design and analysis of genetic association studies. The lab performed association studies that led to the discovery of over three dozen novel genomic loci harboring causal variants influencing type 2 diabetes, serum lipids, prostate cancer, systemic lupus erythematosis and rheumatoid arthritis. They have studied these and other variants previously identified to begin exploring their contributions to physiology and clinical medicine.